Abeona Therapeutics Inc.

NASDAQ: ABEO · Real-Time Price · USD
7.12
-0.11 (-1.52%)
At close: Aug 15, 2025, 3:59 PM
7.13
0.14%
After-hours: Aug 15, 2025, 06:57 PM EDT

Abeona Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
15.94M 23.36M 15.73M 34.43M 17.56M 14.47M 4.71M 6.22M 4.68M 14.22M 5.73M 6.13M 20.33M 32.94M 43.78M 27.18M 14.27M
Short-Term Investments
68.22M 74.36M 93.97M 88.28M 44.79M 37.75M 49.04M 30.55M 35.68M 37.93M 12.43M 13.96M 10.99M 12.09M 23.22M 50.38M 72.51M
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
57K 96K 88K 100K 114K 277K 139K 108K 99K 43K 20K 20K 20K 168K 1.16M 1.16M 1.16M
Receivables
1.62M 1.65M 1.61M 1.64M 2.23M 2.44M 2.21M 5.73M 519K 188K 1.05M 2.87M n/a 3M n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
2.35M 1.48M 1.34M 1.56M 2.15M 1.07M 1.3M 1.54M 1.96M 762K 5.34M 5.89M 5.89M 891K n/a n/a n/a
Total Current Assets
88.12M 100.85M 112.66M 125.9M 66.72M 55.74M 57.26M 44.04M 42.84M 53.1M 25.5M 30.3M 39.2M 56.29M 67.91M 78.88M 88.6M
Property-Plant & Equipment
11.19M 7.98M 7.85M 8M 7.99M 7.99M 8.68M 9.4M 10.4M 11.07M 13.24M 14.4M 15.95M 21.74M 16.08M 16.73M 17.74M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.38M 33.88M 33.91M 33.94M
Total Long-Term Assets
11.24M 8.08M 7.93M 8.1M 8.1M 8.27M 8.82M 9.51M 10.5M 11.12M 13.26M 14.42M 15.97M 23.29M 51.11M 51.8M 52.84M
Total Assets
99.36M 108.93M 120.59M 134M 74.83M 64M 66.09M 53.55M 53.34M 64.21M 38.76M 44.72M 55.17M 79.59M 119.02M 130.68M 141.43M
Account Payables
5.02M 3.44M 2.79M 3.1M 3.36M 1.86M 2.59M 3.48M 2.86M 1.81M 1.75M 1.74M 1.6M 4.33M 1.86M 1.47M 2.48M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 296K 296K 296K 296K
Short-Term Debt
8.76M 5.93M 4.44M 2.22M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.76M 549K
Other Current Liabilities
4.2M 4.46M 3.74M 3.42M 1.33M 3.69M 2.33M 1.64M 1.04M 2.8M 2.09M 1.85M 745K 1.79M n/a n/a n/a
Total Current Liabilities
17.98M 16.59M 18.42M 16.84M 11.89M 13.42M 8.41M 9.44M 7.42M 7.78M 12.6M 13.69M 12.34M 16.62M 26.47M 41.87M 40.84M
Long-Term Debt
15.22M 13.04M 14.21M 16.13M 18.08M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.21M
Other Long-Term Liabilities
24.77M 32.01M 38.79M 24.77M 49.7M 31.35M 31.59M 30.39M 21.66M 23.82M 4.26M 4.21M 4.12M 13.04M 8.36M n/a n/a
Total Long-Term Liabilities
39.98M 48.31M 56.4M 43.92M 71.82M 35.75M 35.64M 34.77M 27.18M 29.67M 10.75M 10.95M 11.39M 20.59M 12.8M 4.72M 6.2M
Total Liabilities
57.97M 64.9M 74.82M 60.76M 83.71M 49.18M 44.05M 44.2M 34.6M 37.45M 23.35M 24.63M 23.73M 37.22M 39.27M 46.59M 47.04M
Total Debt
23.98M 23.05M 23.11M 23.16M 23.17M 5.4M 5.69M 5.97M 7.32M 7.63M 8.29M 8.54M 9.1M 9.38M 6.17M 8.2M 8.47M
Common Stock
490K 457K 434K 417K 276K 265K 247K 215K 179K 177K 77K 1.47M 1.47M 1.47M 1.02M 1.01M 990K
Retained Earnings
-825.29M -813.26M -803.97M -773.7M -781.1M -749.52M -732.93M -721.1M -704.44M -695.34M -694.21M -684.73M -676.43M -655.64M -608.96M -601.91M -586.71M
Comprehensive Income
-67K 8K -84K -134K -184K -66K -99K -95K -65K -129K -44K -34K -30K -27K -9K -1K 3K
Shareholders Equity
41.4M 44.03M 45.77M 73.24M -8.88M 14.83M 22.04M 9.35M 18.74M 26.76M 15.41M 20.09M 31.44M 42.37M 79.74M 84.09M 94.39M
Total Investments
68.22M 74.36M 93.97M 88.28M 44.79M 37.75M 49.04M 30.55M 35.68M 37.93M 12.43M 13.96M 10.99M 12.09M 23.22M 50.38M 72.51M